Pioglitazone also suppresses COX-2 expression and inhibits the metastasis of colon cancer cells in vivo (26), and it may inhibit xenograft angiogenesis through the inhibition of IL-8 and COX-2 mRNA expression. This evidence concerns the gene PTGS2 and colonic neoplasm.